Ana Catarina Silva

senior researcher

Associate Professor (since 2021)
Personal Website
Phone number
Ciência Vitae

Recent publications

  • S. Cunha and M. Swedrowska and Y. Bellahnid and Z. Xu and J.M. Sousa Lobo and Ben Forbes and A.C. Silva. 2022. Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition studies. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 620, DOI: 10.1016/j.ijpharm.2022.121720
  • Cláudia Pina Costa, João Nuno Moreira, José Manuel Sousa Lobo, Ana CatarinaSilva. 2021. Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies. Acta Pharmaceutica Sinica B, DOI: 10.1016/j.apsb.2021.02.012
  • Ana Catarina Silva, João Nuno Moreira, José Manuel Sousa Lobo, Hugo Almeida. 2020. Current Applications of Pharmaceutical Biotechnology. SpringerPlus, DOI: 10.1007/978-3-030-40464-2
  • CCosta; JNMoreira; MHAmaral; JMSousa Lobo; ACSilva. 2019. Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis. JOURNAL OF CONTROLLED RELEASE, 295, DOI: 10.1016/j.jconrel.2018.12.049

Main research interests

  • Development and characterization of lipid nanoparticles-based formulations for nasal, cutaneous and oral administration
  • Drug delivery for neurodegenerative diseases, epilepsy and anxiety emergency therapy
  • Skin biocompatibility and cutaneous hydration potential of lipid nanoparticles-based formulations
  • In vitro correlations for drug delivery from lipid nanoparticles vs. cell culture models. Modelling kinetic profiles
  • Delivery systems for biopharmaceuticals